November 19, 2024

---

Lavie Bio advances its bio-fungicide LAV321, targeting downy mildew, to pre-commercial stage following successful 2024 field trial results

November 12, 2024

---

Lavie Bio announces commercial expansion of Yalos as seed treatment for soybean, following successful field trials

September 30, 2024

---

Lavie Bio receives grant from Israel Innovation Authority to advance the development of ‘MicroFermentor’, a unique technology that can change the economics of ag-biologicals

August 22, 2024

---

Evogene reports second quarter 2024 financial results

July 17, 2024

---

ICL and Lavie Bio leverage artificial intelligence to make significant advancement in the development of yield increasing bio-stimulants

July 2, 2024

---

Lavie Bio announces commercial expansion of its bio-inoculant product, Yalos, to winter wheat

April 5, 2024

---

Syngenta and Lavie Bio team up to speed up the R&D process for biopesticides (AFN)

March 19, 2024

---

Bayer AG and Lavie Bio continue for second year of biofungicides validation following successful lab and greenhouse testing

March 13, 2024

---

Lavie Bio and Ceres Global Ag Corp. collaborate to include Yalos bio-inoculant in regenerative agriculture initiatives in North America

March 7, 2024

---

Evogene reports fourth quarter and full year 2023 financial results

February 28, 2024

---

Lavie Bio successfully secures second half advance payment of $2.5M after meeting Corteva’s licensing agreement requirements

February 20, 2024

---

Syngenta and Lavie Bio announce partnership to discover and develop novel bio-insecticide

December 5, 2023

---

Lavie Bio announces a distribution agreement with WinField United Canada for its bio-inoculant seed treatment Yalos

November 28, 2023

---

Lavie Bio announces expansion of its bio-inoculant product for spring wheat, Yalos, to durum and barley

November 8, 2023

---

Lavie Bio reports advancement in bio-fungicide program against downy mildew with 2023 field trial results

July 17, 2023

---

Lavie Bio announces licensing agreement for bio-fungicides with Corteva Agriscience - Corteva to receive exclusive rights to further develop and commercialize Lavie Bio’s lead product candidates for fruit rot and powdery mildew fungicide biologicals

May 24, 2023

---

Lavie Bio receives Canadian regulatory approval for its bio-inoculant seed treatment Thrivus, expanding global reach

March 29, 2023

---

Lavie Bio announces appointment of Amit Noam as its incoming Chief Executive Officer

February 28, 2023

---

Lavie Bio reports successful results for its bio-fungicides programs

October 12, 2022

---

Lavie Bio advances its novel bio-fungicide program and applies to the U.S. EPA for regulatory approval - LAV.311 is targeting fruit rots and powdery mildews fungal diseases

September 14, 2022

---

Lavie Bio announces appointment of Guri Oron as CEO

August 18, 2022

---

ICL and Lavie Bio enter strategic collaboration to develop novel bio-stimulant products

June 13, 2022

---

Lavie Bio announces successful product launch of its bio-inoculant Result for the 2022 spring wheat growing season

December 14, 2021

---

Lavie Bio reports advancement in its bio-fungicide program for fruit rots

November 3, 2021

---

Lavie Bio announces commercial launch of its first microbiome-based product for yield improvement under the name Result - Result inoculant initially introduced for spring wheat in North Dakota, following positive four-year field trials

September 29, 2021

---

Lavie Bio and United Agronomy announce signing of distribution agreement for Lavie Bio’s inoculant product - Commercialization targeted for 2022 for spring wheat initially

May 25, 2021

---

Lavie Bio announces the appointment of Russ Putland as Vice President Commercial

December 30, 2020

---

Lavie Bio provides product pipeline update for 2020

November 18, 2019

---

Lavie Bio announces advancement in its product development pipeline for wheat bio-stimulants - Leading wheat bio-stimulant candidate for spring wheat, exhibiting consistent performance, advancing to 'development stage 2', in line with Lavie Bio's commercialization plans for 2022

September 11, 2019

---

“If you can’t beat ’em, join ’em” – how crop tech startups like Lavie Bio chart the market (AgFunder News)